XML 180 R165.htm IDEA: XBRL DOCUMENT v2.4.0.8
Parent Company Financial Statements (Schedule Of Condensed Statements Of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Condensed Financial Statements, Captions [Line Items]      
Net income $ 98,361 $ 101,891 $ 74,496
Depreciation, amortization and accretion 18,267 16,040 13,151
Change in fair value of junior subordinated debentures 2,193 2,175 2,217
Net (increase) decrease in other assets 32,129 5,401 (15,404)
Net (decrease) increase in other liabilities (7,589) 22,255 15,177
Net cash provided by operating activities 413,097 26,485 182,352
Net cash used by investing activities 281,072 121,519 (382,744)
Dividends paid on common stock (50,768) (46,201) (25,317)
Stock repurchased (9,360) (7,436) (29,754)
Proceeds from exercise of stock options 6,398 981 308
Net cash used by financing activities (447,533) (202,983) (204,967)
Change in cash and cash equivalents 246,636 (54,979) (405,359)
Cash and cash equivalents, beginning of year 543,787 598,766 1,004,125
Cash and cash equivalents, end of year 790,423 543,787 598,766
Umpqua Bank [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net income 98,361 101,891 74,496
Equity in undistributed earnings of subsidiaries (43,381) (30,054) (64,096)
Depreciation, amortization and accretion (322) (322) (322)
Change in fair value of junior subordinated debentures 2,193 2,182 2,217
Net (increase) decrease in other assets (92) 4,925 (3,933)
Net (decrease) increase in other liabilities (1,361) (1,184) 3,736
Net cash provided by operating activities 55,398 77,438 12,098
Investment in subsidiaries (2,928) (24,970) (3,668)
Acquisitions 0 419 0
Net decrease in receivables from nonbank subsidiaries 0 0 8
Net cash used by investing activities (2,928) (24,551) (3,660)
Net (decrease) increase in payables to subsidiaries (8,448) 17 7
Dividends paid on common stock (50,767) (46,201) (25,317)
Stock repurchased (9,356) (7,433) (29,754)
Proceeds from exercise of stock options 6,397 980 309
Net cash used by financing activities (62,174) (52,637) (54,755)
Change in cash and cash equivalents (9,704) 250 (46,317)
Cash and cash equivalents, beginning of year 82,383 82,133 128,450
Cash and cash equivalents, end of year $ 72,679 $ 82,383 $ 82,133